» Articles » PMID: 32547940

Isolated Pancreatic Metastases of Renal Cell Carcinoma-A Paradigm of a Seed and Soil Mechanism: A Literature Analysis of 1,034 Observations

Overview
Journal Front Oncol
Specialty Oncology
Date 2020 Jun 18
PMID 32547940
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Previously documented arguments, in favor of the suspected impact of a seed and soil mechanism, in the development and progression of isolated pancreatic metastasis of renal cell carcinomas (isPM) are: (1) uniform and independent from the side of the primary tumor distribution of isPM within the pancreas and, (2) the similar survival rates for singular and multiple isPM. In addition, the present study adds new arguments that further confirm the importance of an seed and soil mechanism in isPM: (1) Within the singular isPM, the size of the metastasis does not affect the overall survival; (2) Within the group of multiple isPMs, the overall survival does not depend on the number of metastases; (3) For synchronous and metachronous isPM, survival rates are also not different, and (4) Within the group of metachronous isPM there is also no correlation between the overall survival and interval until metastases occurs. This unusual ineffectiveness of otherwise known risk factors of solid cancers can be explained plausibly by the hypothesis of a very selective seed and soil mechanism in isPM. It only allows embolized renal carcinoma cells in the pancreas to complete all steps required to grow into clinically manifest metastases. In all other organs, on the other hand, the body is able to eliminate the embolized tumor cells or at least put them into a dormant state for many years. This minimizes the risk of occult micrometastases in distant organs, which could later-after isPM treatment-grow into clinically manifest metastases, so that the prognosis of the isPM is only determined by an adequate therapy of the pancreatic foci, and prognostic factors, such as total tumor burden or interval until the occurrence of the isPM remain ineffective.

Citing Articles

The Role of Endoscopic Ultrasonography (EUS) in Metastatic Tumors in the Pancreas: 10 Years of Experience from a Single High-Volume Center.

Aversano A, Lissandrini L, Macor D, Carbone M, Cassarano S, Marino M Diagnostics (Basel). 2024; 14(12).

PMID: 38928665 PMC: 11202536. DOI: 10.3390/diagnostics14121250.


Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.

Sellner F, Comperat E, Klimpfinger M Int J Mol Sci. 2023; 24(22).

PMID: 38003482 PMC: 10671160. DOI: 10.3390/ijms242216292.


Identification of a Novel Myc-Regulated Gene Signature for Patients with Kidney Renal Clear Cell Carcinoma.

Fu S, Liu Y, Zhang Z, Mei M, Chen Q, Wang S J Oncol. 2023; 2022:3487859.

PMID: 37342680 PMC: 10279501. DOI: 10.1155/2022/3487859.


Metastatic Renal Cell Carcinoma to Pancreas: Case Series and Review of the Literature.

Balaban D, Coman L, Marin F, Balaban M, Tabacelia D, Vasilescu F Diagnostics (Basel). 2023; 13(8).

PMID: 37189469 PMC: 10137405. DOI: 10.3390/diagnostics13081368.


Isolated Pancreatic Metastases of Renal Cell Carcinoma-Clinical Particularities and Seed and Soil Hypothesis.

Sellner F, Thalhammer S, Klimpfinger M Cancers (Basel). 2023; 15(2).

PMID: 36672289 PMC: 9857376. DOI: 10.3390/cancers15020339.


References
1.
Schwarz L, Sauvanet A, Regenet N, Mabrut J, Gigot J, Housseau E . Long-term survival after pancreatic resection for renal cell carcinoma metastasis. Ann Surg Oncol. 2014; 21(12):4007-13. DOI: 10.1245/s10434-014-3821-4. View

2.
Takeshi A, Mitsuhiro I, Hiromitsu A, Naoyuki Y, Taiichiro S, Hiroki S . Middle segment-preserving pancreatectomy for recurrent metastasis of renal cell carcinoma after pancreatoduodenectomy: a case report. Case Rep Surg. 2014; 2014:648678. PMC: 4100267. DOI: 10.1155/2014/648678. View

3.
Sonmez M, Ozturk Sonmez L . New treatment modalities with vaccine therapy in renal cell carcinoma. Urol Ann. 2019; 11(2):119-125. PMC: 6476201. DOI: 10.4103/UA.UA_166_17. View

4.
Hung J, Wang S, Shyr Y, Su C, Chen T, Wu C . Resection for secondary malignancy of the pancreas. Pancreas. 2011; 41(1):121-9. DOI: 10.1097/MPA.0b013e31821fc8f2. View

5.
Shrikhande S, Buchler P, Esposito I, Loos M, Buchler M, Friess H . Splenic and portal vein thrombosis in pancreatic metastasis from renal cell carcinoma. World J Surg Oncol. 2006; 4:25. PMC: 1482706. DOI: 10.1186/1477-7819-4-25. View